HLTH - Cue Health Inc.
| Previous close | 0.5326 |
| Open | 0.5490 |
| Bid | 0.5452 x 800 |
| Ask | 0.5453 x 800 |
| Day's range | 0.5326 - 0.5686 |
| 52-week range | 0.5120 - 5.1000 |
| Volume | |
| Avg. volume | 518,890 |
| Market cap | 93.179M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
SAN DIEGO, June 06, 2023--Cue Health (Nasdaq: HLTH), a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and Drug Administration (FDA) for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use. This sets a new standard as the first FDA De Novo authorization for a home use COVID-19 test and the first De Novo granted for any home use respiratory test.
- Business Wire
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
SAN DIEGO, Calif., May 31, 2023--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 4:00 p.m. Pacific Time at the Waldorf Astoria Monarch Beach Resort & Club.
- Business Wire
Cue Health Reports First Quarter 2023 Financial Results
SAN DIEGO, May 10, 2023--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the first quarter 2023.
- Business Wire
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
SAN DIEGO, May 09, 2023--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test for at-home and point-of-care use. There are currently no respiratory syncytial virus (RSV) tests on the market for home use. Pending FDA clearance, Cue’s test would provide the public, for the first time, an at-home molecular RSV test to use on people of a
- Business Wire
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
SAN DIEGO, May 08, 2023--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with over-the-counter and prescription medication options for a growing number of common health and wellness needs. These include sexual health - such as erectile dysfunction and herpes - as well as birth control, hair loss, and more.
- Business Wire
Cue Health to Announce First Quarter 2023 Financial Results
SAN DIEGO, April 26, 2023--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
- Business Wire
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
SAN DIEGO, March 20, 2023--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its molecular test to detect the mpox virus (formerly known as monkeypox). This nucleic acid amplification test (NAAT) is run on a Cue Reader, can be performed at any CLIA-waived facility and delivers results in 25 minutes, significantly expanding access to fast and accurate t
- Business Wire
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
SAN DIEGO, March 15, 2023--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022.
- Business Wire
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
SAN DIEGO, March 13, 2023--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits. These easy-to-use kits provide individuals with access to accurate, reliable testing from the comfort of their own homes, making it easier for people to take control of their health. The tests are integrated into Cue Care – the company’s innovative test-to-treat service. Cue provides personalized ca
- Business Wire
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
SAN DIEGO, March 02, 2023--Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology leader in at-home and point-of-care diagnostic innovations, today announced a new collaboration with Pfizer Inc. in the U.S. to raise awareness among individuals with certain underlying conditions about the risks of progressing to severe COVID-19 and the importance of seeking treatment if they test positive. Through Cue Care, Cue’s same-day, at-home, test-to-treatment platform, individuals will be able to use
- Business Wire
Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results
SAN DIEGO, March 01, 2023--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2022 financial results on Wednesday, March 15, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
- Business Wire
Cue Health to Participate at Upcoming Investor Conferences
SAN DIEGO, February 02, 2023--Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, announced today that its management team will participate at the following investor conferences:
- Business Wire
Cue Health Selected by Minnesota Department of Health to Provide Statewide Telehealth to Treatment Services to all Minnesota Residents at No Cost
SAN DIEGO, December 22, 2022--Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, today announced that it has been selected by Minnesota Department of Health (MDH) to provide a statewide COVID-19 telehealth to treatment program, powered by Cue Care™, at no cost to Minnesota residents.
- Business Wire
Cue Health Announces Appointment of Josh Ghaim, Ph.D. and Sachin Jain, M.D. to its Board of Directors
SAN DIEGO, November 17, 2022--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced that Josh Ghaim, Ph.D. and Sachin Jain, M.D. have joined its Board of Directors. Cue Health’s Board now consists of seven directors, five of whom are independent.
- Business Wire
Cue Health Reports Third Quarter 2022 Results
SAN DIEGO, November 09, 2022--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter of 2022.
- Business Wire
Cue Health to Announce Third Quarter 2022 Financial Results
SAN DIEGO, October 26, 2022--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2022 financial results on Wednesday, November 9, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
- Business Wire
Cue Health to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
SAN DIEGO, August 30, 2022--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022 at 4:40 p.m. Eastern Time in New York, NY.
- Business Wire
Cue Health Reports Second Quarter 2022 Results
SAN DIEGO, August 10, 2022--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the second quarter of 2022.
- Business Wire
Cue Health to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
SAN DIEGO, August 03, 2022--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 16, 2022.
- Business Wire
Cue Health to Announce Second Quarter 2022 Financial Results
SAN DIEGO, July 27, 2022--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
